A new approach to Pharma GDP
Building on current quality and risk-management best practices,
the GDP-UCI seeks to modernise and improve the distribution of
vaccines and medicines by applying consensus- and evidence-
based improvements and by harmonising GDP processes. The goal
is one of improving patient wellbeing through the pursuit of more
consistent, compatible, measurable and efficient methods.
Integrated compliance
Ultimately everyone involved with GDP has the end-goal of
improving patient safety and patient outcomes. The GDP·UCI is
unique in that its involvement encompasses the entire
pharmaceutical supply chain. This includes actors at all levels, from
manufacturers and distributors to carriers, logistics service
companies, solution providers and support organisations.
Good Distribution Practice - Universal Compliance Initiative
Aimed at the entire pharmaceutical distribution chain, the GDP Universal Compliance Initiative is an
industry-owned and industry-led undertaking being designed to bring certainty, consistency, and
continuous improvement to the process of meeting international quality and regulatory standards for
the safe, efficient and sustainable distribution of medicines and vaccines.
Collaboration, Consensus and Unity
To enact meaningful industry-wide change requires individual people and individual companies to see
beyond their competitive differences and work towards common goals.
The world’s first and only GDP reform initiative
